Milestone Scientific Inc. (NYSEAMERICAN:MLSS) CFO Joseph D’agostino sold 45,000 shares of the company’s stock in a transaction that occurred on Wednesday, December 27th. The shares were sold at an average price of $1.07, for a total value of $48,150.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Joseph D’agostino also recently made the following trade(s):

  • On Wednesday, December 13th, Joseph D’agostino sold 52,980 shares of Milestone Scientific stock. The shares were sold at an average price of $1.05, for a total value of $55,629.00.
  • On Tuesday, December 5th, Joseph D’agostino sold 15,000 shares of Milestone Scientific stock. The shares were sold at an average price of $1.05, for a total value of $15,750.00.

Milestone Scientific Inc. (MLSS) traded down $0.04 during mid-day trading on Thursday, reaching $1.10. The company had a trading volume of 40,000 shares, compared to its average volume of 38,030. Milestone Scientific Inc. has a 12-month low of $0.91 and a 12-month high of $1.80. The stock has a market cap of $37.13, a price-to-earnings ratio of -6.88 and a beta of 0.84.

MLSS has been the topic of a number of recent research reports. ValuEngine raised Milestone Scientific from a “sell” rating to a “hold” rating in a research note on Friday, September 8th. Maxim Group reaffirmed a “buy” rating and issued a $4.00 target price on shares of Milestone Scientific in a research note on Friday, October 6th.

WARNING: This piece was reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another publication, it was stolen and republished in violation of US and international copyright law. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/12/28/milestone-scientific-inc-mlss-cfo-sells-48150-00-in-stock.html.

About Milestone Scientific

Milestone Scientific Inc (Milestone) is engaged in providing computer-controlled injection technologies and solutions for the medical and dental markets. The Company uses its CompuFlo technology for the delivery of medicaments. The CompuFlo pressure or force Computer-Controlled Local Anesthetic Delivery (C-CLAD) technology is a medical technology for the delivery of drugs, anesthetics and other medicaments into various tissue types.

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.